Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 4 (5) , 314-321
- https://doi.org/10.1054/drup.2001.0219
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Aspirin and risk for gastric cancer: a population-based case–control study in SwedenBritish Journal of Cancer, 2001
- Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory DrugsEpidemiology, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- Recent advances in research on multistage tumorigenesisBritish Journal of Cancer, 2000
- Checkpoint for invasionNature, 2000
- Nonsteroidal Anti-Inflammatory Drugs and Cancer PreventionAnnual Review of Medicine, 2000
- The role of cyclooxygenases in inflammation, cancer, and developmentOncogene, 1999
- The Role of Cyclooxygenase Inhibition in the Antineoplastic Effects of Nonsteroidal Antiinflammatory Drugs (Nsaids)The Journal of Experimental Medicine, 1999
- Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous PolyposisNew England Journal of Medicine, 1993
- Aspirin Use and Reduced Risk of Fatal Colon CancerNew England Journal of Medicine, 1991